Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro

View through CrossRef
AbstractThe embryotoxicity of the antimalarial drug chloroquine (CQ) was evaluated in vitro using the rat whole embryo culture system. CQ was found to be embryotoxic and dysmorphogenic when added directly to the culture media containing gestational day (GD) 10 rat conceptuses. Twenty‐six‐hr exposure to CQ elicited dose‐related decreases in embryonic crown‐rump length, protein and DNA contents and increases in the incidence of morphologically abnormal embryos. At 30 μM CQ, embryonic protein content was decreased to 67% and DNA content to 58% of control while the incidence of morphological abnormalities rose to 100%. Abnormal axial rotation, microophthalmia, and selective cephalic hypoplasia were the most common developmental abnormalities observed. Visceral yolk sac (VYS) vasculature and blood pigmentation were also decreased in a dose‐dependent manner, as was VYS DNA content (80% of control at 30 μM). VYS protein content, however, showed an alternate pattern of response, decreasing to 87% of control at 10 μM CQ but increasing to 125% of control at 30 μM. Histologic evaluation revealed that the cytoplasm of the VYS endoderm epithelium was distended due to vacuolization produced by CQ exposure. In the embryo proper, CQ inhibited cranial neural tube development and altered the morphology of cranial neural crest cells. These observations document the in vitro embryotoxicity of CQ and suggest altered VYS histiotrophic nutrition as well as direct embryonic effects as possible mechanisms of CQ embryotoxicity. © 1993 Wiley‐Liss, Inc.
Title: Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro
Description:
AbstractThe embryotoxicity of the antimalarial drug chloroquine (CQ) was evaluated in vitro using the rat whole embryo culture system.
CQ was found to be embryotoxic and dysmorphogenic when added directly to the culture media containing gestational day (GD) 10 rat conceptuses.
Twenty‐six‐hr exposure to CQ elicited dose‐related decreases in embryonic crown‐rump length, protein and DNA contents and increases in the incidence of morphologically abnormal embryos.
At 30 μM CQ, embryonic protein content was decreased to 67% and DNA content to 58% of control while the incidence of morphological abnormalities rose to 100%.
Abnormal axial rotation, microophthalmia, and selective cephalic hypoplasia were the most common developmental abnormalities observed.
Visceral yolk sac (VYS) vasculature and blood pigmentation were also decreased in a dose‐dependent manner, as was VYS DNA content (80% of control at 30 μM).
VYS protein content, however, showed an alternate pattern of response, decreasing to 87% of control at 10 μM CQ but increasing to 125% of control at 30 μM.
Histologic evaluation revealed that the cytoplasm of the VYS endoderm epithelium was distended due to vacuolization produced by CQ exposure.
In the embryo proper, CQ inhibited cranial neural tube development and altered the morphology of cranial neural crest cells.
These observations document the in vitro embryotoxicity of CQ and suggest altered VYS histiotrophic nutrition as well as direct embryonic effects as possible mechanisms of CQ embryotoxicity.
© 1993 Wiley‐Liss, Inc.

Related Results

Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
Ruminant conceptus-maternal interactions: interferon-tau and beyond
Ruminant conceptus-maternal interactions: interferon-tau and beyond
Abstract Embryonic or fetal loss in cattle is associated with problems that occur during oocyte maturation, early embryonic development, conceptus elongation, matern...
Plasmodium vivax trophozoites insensitive to chloroquine
Plasmodium vivax trophozoites insensitive to chloroquine
AbstractBackgroundPlasmodium vivaxis a major cause of malaria and is still primarily treated with chloroquine. Chloroquine inhibits the polymerization of haem to inert haemozoin. F...
To determine morphology after administration of tetracycline and zinc chloride in adult albino rats and prenatal conceptus.
To determine morphology after administration of tetracycline and zinc chloride in adult albino rats and prenatal conceptus.
Introduction: Administration of tetracycline therapy is controversial during growing age as stated by earlier workers. However the effect of simultaneous administration of tetracyc...
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
Embryotoxicity of the intercalating agents m‐AMSA and o‐AMSA and the epipodophyllotoxin VP‐16 in postimplantation rat embryos in vitro
AbstractThe intercalating agent, m‐AMSA, and the epipodophyllotoxin, VP‐16, both topoisomerase II—reactive anticancer agents, are also embryotoxic agents in rat embryos cultured in...
Potentiated Embryotoxicity of Pyrimethamine by Folic Acid in Mice
Potentiated Embryotoxicity of Pyrimethamine by Folic Acid in Mice
ABSTRACT Effects of folic acid (FA) and folinic acid (FNA) on the embryotoxicity of pyrimethamine (PYR), an antifolate drug, were examined in mice. PYR and FA were administered ora...
Long cryopreserved lab-adapted Plasmodium falciparum increases resistance to chloroquine but not its susceptibility
Long cryopreserved lab-adapted Plasmodium falciparum increases resistance to chloroquine but not its susceptibility
Introduction: Plasmodium falciparum (P. falciparum) is a deadly protozoan that is accountable for malaria and chloroquine was the first-line antimalarial drug before its withdrawal...
Companion diagnostic for the chloroquine use in the treatment of COVID-19: systems biology report of candidate markers.
Companion diagnostic for the chloroquine use in the treatment of COVID-19: systems biology report of candidate markers.
Abstract BACKGROUND Chloroquine is used for the treatment of COVID-19 patients. However, efficacy of the chloroquine has been under discussion. Variability of clinical out...

Back to Top